Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

This study has been completed.

Study NCT00299520 Information provided by Arpida AG

First Received: March 3, 2006 Last Updated: April 2, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2006
Estimated Primary Completion Date:	No date given